The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Prognostic value of plasma endothelin-1 in patients with chronic heart failure
Abstract
AIMS: Endothelin-1 is a potent vasoconstrictive and multifunctional peptide. Elevated concentrations have been reported in congestive heart failure. We hypothesized that the level of endothelin-1 in plasma is a prognostic marker in congestive heart failure. METHODS AND RESULTS: Plasma levels of endothelin-1 were measured by radioimmunoassay in 120 congestive heart failure patients with ischaemic or non-ischaemic cardiomyopathy (mean ejection fraction 28 +/- 11%, in New York Heart Association (NYHA) functional class I:21, class II 35, class III: 61, class IV: 3). During a median follow-up of 361 +/- 338 days, 14 cardiac deaths occurred. In the univariate Cox model, endothelin-1 was the most powerful prognostic marker among the variables tested (P = 0.0001). A multivariate model, including plasma atrial natriuretic peptide and noradrenaline, NYHA class, age, and echocardiographic left ventricular end-diastolic diameter index was highly predictive of mortality (P = 0.00008), but only endothelin-1 remained significantly associated with outcome (P = 0.02). Patients with plasma endothelin-1 > or = 5 pg. ml-1 had a higher mortality rate than those with endothelin-1 < 5 pg. ml-1 (21% vs 4%, P = 0.001). CONCLUSION: Our results suggest that elevated endothelin-1 plasma levels are associated with a poor prognosis and routine plasma endothelin-1 determination provides important prognostic information in mild to moderate heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Cited by
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Gardner, R. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.005 · Cited by 448
Bolger, A. P., Sharma, R., Li, W., Leenarts, M., Kalra, P. R., Kemp, M., Coats, A. J. S., Anker, S. D., & Gatzoulis, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000020009.30736.3f · Cited by 419
Kalra, P. R., Moon, J. C. C., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00182-1 · Cited by 293
Packer, M., McMurray, J., Massie, B. M., Caspi, A., Charlon, V., Cohen-Solal, A., Kiowski, W., Kostuk, W., Krum, H., Levine, B., et al. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.006 · Cited by 275
Metadata
- Authors
- Pousset, F., Isnard, R., Lechat, P., Kalotka, H., Carayon, A., Maistre, G., Escolano, S., Thomas, D., & Komajda, M.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-02-02
- Volume
- 18
- Issue
- 2
- Pages
- 254-258
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2074113957
- Cited by
- 239
- References
- 1
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic value of plasma endothelin-1 in patients with chronic heart failure. https://app.cochat.ai/papers/10.1093/oxfordjournals.eurheartj.a015228
- The paper
- Pousset, F., Isnard, R., Lechat, P., Kalotka, H., Carayon, A., Maistre, G., Escolano, S., Thomas, D., & Komajda, M. (1997). Prognostic value of plasma endothelin-1 in patients with chronic heart failure. European Heart Journal. https://doi.org/10.1093/oxfordjournals.eurheartj.a015228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.